Chunning Zhang

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients

Jiexia Zhang, Xiangyang Cheng, Xue Hu, 2022, Frontiers in Oncology.

How to determine post-RCHOP therapy for risk-tailored adult patients with diffuse large B-cell lymphoma, addition of maintenance rituximab or observation: multicenter experience

Zhen Xiao, Jessica A. Yu, Bin-Tao Huang, 2011, Journal of Cancer Research and Clinical Oncology.

First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

Chong-xiang Chen, Jiexia Zhang, Chengzhi Zhou, 2022, Therapeutic advances in chronic disease.

A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers

Shulin Chen, Hualiang Lv, Hao Chen, 2020, Cancer medicine.

Molecular Characterization and Clinical Relevance of Lysine Acetylation Regulators in Urological Cancers

Yawei Yuan, Jian Zhang, Huali Jiang, 2021, Frontiers in Oncology.

Prediction of effective percutaneous transhepatic biliary drainage in patients with hepatocellular carcinoma: A multi-central retrospective study

Bin Chen, Y. Mao, Xiaojun Hu, 2022, Liver Research.

FOXD1 is a prognostic biomarker and correlated with macrophages infiltration in head and neck squamous cell carcinoma

Chaoming Li, Hua-ming Lin, Huazhen Liang, 2021, Bioscience reports.